Tag Archives: government

UK-HPA

Posted on March 11, 2013 by KSW | Leave a comment

HPA welcomes move to put antibiotic resistance on the national risk register

11 March 2013

The Health Protection Agency (HPA) welcomes the move by England’s Chief Medical Officer (CMO), Professor Dame Sally Davies to add antibiotic resistance to the national risk register.

Its addition to the risk register will mean that this issue will be given full attention by politicians here in England as well as the G8 and World Health Organization.

This announcement was made at the launch of the Annual Report of the Chief Medical Officer – Infections and the rise of antimicrobial resistance which was published today.

Figures from the HPA’s Antimicrobial Resistance Reference Laboratory show that in 2003 there were three samples which tested positive for antibiotic resistance compared to 800 in 2012.

It is this dramatic rise in the numbers of cases that warrants active intervention not just from Government but also from healthcare institutions, the pharmaceutical industry, patients and the general public to address this very serious problem.

USA – FDA – Releases Food Safety Rules

Posted on January 7, 2013 by KSW | 1 comment

Food Safety News

After a year-long delay, two sweeping new food safety rules that will for the first time mandate produce safety standards and preventive controls nationwide will be released today and published to the Federal Register on Monday, according to the U.S. Food and Drug Administration.

“It’s a big deal that these two are coming out because it’s the central framework for prevention,” said Michael Taylor, FDA’s Deputy Comissioner for Foods and Veterinary Medicine, in an interview with Food Safety News. “We’re eager to get to the next phase of the process.”

The two rules were mandated by the Food Safety Modernization Act (FSMA) — a law that aims to shift the U.S. food safety system from being primarily reactive to focusing on prevention — which President Obama signed into law, with broad bipartisan support, exactly two years ago.

Since the law was enacted, the FDA has failed to keep up with the multiple deadlines set by Congress, in large part because the measures proposed by the agency were under review at the White House Office of Management and Budget’s Office of International and Regulatory Affairs for more than a year — a delay many stakeholders blamed on election politics.